Industrious Pharmaceuticals
Warp speed is amazoning pharma practices and protocols.
The Long Path to Normal
Survey respondents reflect on the state and future of the bio/pharma employment.
What’s Next for COVID-19 Vaccines and Variants?
Although mRNA and viral vector vaccines have been top of mind for COVID-19 treatments, other technologies and treatments are emerging—along with new variants.
Recent Trends in Data Analytics for Upstream Process Workflows
Modeling techniques can improve process control and monitoring in biopharmaceutical production.
Automating Upstream Processes Helps Sync Workflows
Upstream processing is better optimized with the help of automated workflows.
Enhancing Resins Addresses Purification Concerns
Enhancement of resin technology can improve the ability of chromatography to purify the growing landscape of increasingly complex biomolecules.
Qualifying AI Algorithms in Pharmaceutical Manufacturing
Qualified algorithms enable validation of machine learning models that can be used for process optimization.
Quality Still a Priority
As regulators balance pandemic tasks and rethink procedures, quality at manufacturing facilities is still a priority.
Finding Solutions to Cold Chain Supply
New and emerging biotherapeutic molecules drive the need for innovative solutions to meet cold-chain requirements.
Outsourcing’s Race Toward Novelty
Recent developments in the outsourcing industry include a focus on early development services, biosimilar production, and RNA technology.
Multiple Challenges to Multispecific Analysis
Multispecific analysis is complex but can be achieved using appropriate strategies.
Good Manufacturing Practice on Demand?
Siegfried Schmitt, vice president Technical at Parexel, discusses the difficulty of operating non-GMP and GMP quality systems in the same facility.
Major Challenges Ahead for FDA and Pharma
To maintain smooth operations, FDA is relying on swift reauthorization of industry-paid user fee programs.
